Article
Astragaloside IV alleviates skin fibrosis by modulating fibroblast phenotype in keloids.
European journal of dermatology : EJD - 1 Oct 2024
Gao Hu, Sun Xian, Zhang Xiangming
Abstract excerpt
Keloids are fibroproliferative diseases featuring abnormal fibroblast proliferation and extracellular matrix (ECM) deposition. Current therapeutic methods for keloids are unsatisfactory, and the recurrence rates of keloids are high. Astragaloside IV (AS-IV) is a key active component of Astragalus membranaceus Bunge, and has been reported to exert potent anti-fibrotic effects. Accordingly, our research aimed to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
